Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Cell and Region-Specific Targeting of Epitranscriptomic Machinery to Improve Function after Spinal Cord Injury
FY 2023-24
Summary
Spinal cord injury (SCI) is a life-changing event that causes loss of sensorimotor and autonomic functions below the site of injury. To date, there is no effective therapy to promote endogenous neuroprotection, repair, and regeneration post-SCI. At the cellular level, the primary mechanical trauma initiates the secondary injury cascade consisting of vascular disruption, neuroinflammation, excitotoxicity, cell death, and glial scar formation, which creates a growth-suppressive barrier limiting functional recovery. Developing therapies to target a single aspect of the SCI secondary injury cascade results in clinically insignificant recovery, hence, there is an urgent need to develop therapies that can simultaneously target multiple aspects and result in clinically robust recovery of SCI patients. SCI-induced cellular and molecular changes are controlled by cell-specific gene expression levels. Targeting the cell-specific gene regulatory mechanism rather than manipulating individual gene expression provides a promising approach for treating multiple aspects of SCI pathophysiology. The emerging field of epitranscriptomics provides deep insight into the role of reversible post-transcriptional RNA modifications and associated RNA editing proteins in regulating gene expression and consequent cell biology, which provides a wide epitranscriptomic landscape that remains largely unexplored in SCI. In the proposed project, I will determine the cell-specific role of endogenous RNA editing proteins and associated RNA editing of SCI-altered genes underlying secondary injury cascade. Furthermore, I will test the therapeutic potential of cell and region-specific epitranscriptomic gene therapy and pharmacotherapy to mitigate SCI-induced secondary injuries and enhance functional recovery.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506473
Name
Modi Akshat D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Cell and Region-Specific Targeting of Epitranscriptomic Machinery to Improve Function after Spinal Cord Injury
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aav-Mediated Gene Therapy; Cervical Spinal Cord Injury; Drug Repurposing; Endogenous Rna Editing; Epitranscriptomics; Neuroprotection; Neuroregeneration; Neurorepair; Rna Editing Proteins; Single Cell/Nucleus Rna Sequencing
Abstract
Spinal cord injury (SCI) is a life-changing event that causes loss of sensorimotor and autonomic functions below the site of injury. To date, there is no effective therapy to promote endogenous neuroprotection, repair, and regeneration post-SCI. At the cellular level, the primary mechanical trauma initiates the secondary injury cascade consisting of vascular disruption, neuroinflammation, excitotoxicity, cell death, and glial scar formation, which creates a growth-suppressive barrier limiting functional recovery. Developing therapies to target a single aspect of the SCI secondary injury cascade results in clinically insignificant recovery, hence, there is an urgent need to develop therapies that can simultaneously target multiple aspects and result in clinically robust recovery of SCI patients. SCI-induced cellular and molecular changes are controlled by cell-specific gene expression levels. Targeting the cell-specific gene regulatory mechanism rather than manipulating individual gene expression provides a promising approach for treating multiple aspects of SCI pathophysiology. The emerging field of epitranscriptomics provides deep insight into the role of reversible post-transcriptional RNA modifications and associated RNA editing proteins in regulating gene expression and consequent cell biology, which provides a wide epitranscriptomic landscape that remains largely unexplored in SCI. In the proposed project, I will determine the cell-specific role of endogenous RNA editing proteins and associated RNA editing of SCI-altered genes underlying secondary injury cascade. Furthermore, I will test the therapeutic potential of cell and region-specific epitranscriptomic gene therapy and pharmacotherapy to mitigate SCI-induced secondary injuries and enhance functional recovery.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Modi, Akshat D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~